Navigation Links
The Cleft Palate–craniofacial Journal Marks 50 Years of Research With an Ethical Review
Date:1/14/2014

jor areas of change in the editorial process since 1964. Identifying which aspects of the research each author may be responsible for can be difficult now that authorship often entails research teams across multiple sites rather than a single author. Ensuring anonymity of individuals in case studies and photographs also poses new trials in a time of electronic access.

The future promises to bring further scientific advances and, along with them, social and ethical questions. The Cleft Palate–Craniofacial Journal will continue to look back and forward on a variety of topics this coming year while striving to fulfill its primary goal—maximizing the welfare of those we serve.

Full text of the article, “CPCJ 50th Anniversary Editorial Board Commentary: Ethics and Health Policy—Then and Now,” The Cleft Palate-Craniofacial Journal, Vol. 51, No. 1, January 2014, is available at http://www.cpcjournal.org/doi/full/10.1597/13-267.

###

About The Cleft Palate–Craniofacial Journal
The Cleft Palate–Craniofacial Journal is an international, interdisciplinary journal reporting on clinical and research activities in cleft lip/palate and other craniofacial anomalies, together with research in related laboratory sciences. It is the official publication of the American Cleft Palate–Craniofacial Association (ACPA). For more information, visit http://www.acpa-cpf.org/.

Read the full story at http://www.prweb.com/releases/2014/CPCJEthicalReview/prweb11484171.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related medicine news :

1. Thousands of U.S. Babies Born With Cleft Lip, Palate Each Year
2. Cleft lip/palate cause much more than cosmetic problems
3. Sleep Well During The Holidays: Mattress Journal Offers Tips in Latest Article
4. Narconon Arrowhead Oklahoma Featured In Scientific Journal for Outcome Monitoring Procedure
5. The American Journal of Managed Care Finds Health Benefits to Using Mail Order Pharmacies
6. Generation Next Film/Television, Journalism and Social Media Competition Deadline Extended to December 13, 2013
7. Special journal issue focuses on imaging screening
8. Elsevier announces the launch of open access journal: Urology Case Reports
9. HUMAN Ranks #7 on Los Angeles Business Journal’s “Fastest Growing Private Companies” List with Three-Year Sales Growth of 514%
10. Elsevier announces the launch of 2 new open access cardiology journals
11. Healthesystems’ Fall 2013 Issue of RxInformer Journal Offers Guidance and Insights on Challenges Ahead in Workers Compensation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/28/2015)... (PRWEB) March 01, 2015 Heart diseases ... that 10 percent of urban adult population and 5 ... of heart diseases and 20-30 percent of them require ... heart ailments and coronary vascular diseases (CVD). , A ... a new market research report titled “Indian Coronary Stent ...
(Date:2/28/2015)... 28, 2015 The Classic Denture ... a new special. Throughout all of March patients ... , This service can help overall mouth ... pain. Patients may notice certain symptoms that suggest the ... These symptoms include: , 1.    Pain, clicking, and popping in ...
(Date:2/28/2015)... February 28, 2015 A study out ... new gene therapy procedure for the treatment of a ... patients. Authored by Dr. Robert MacLaren, professor ... in the Lancet Medical Journal on January 16, 2014 ... a rare genetic disorder that mostly affects men and ...
(Date:2/28/2015)... Dr. Perry Patel , a dentist ... announced a special offer for the Zoom!® Chairside ... new and established patients at his Pismo Beach dentist office. To ... smile, Dr. Patel and his staff are offering Zoom! ... the regular price of $450. , Zoom! whitening is ...
(Date:2/28/2015)... York, NY (PRWEB) February 28, 2015 On ... Phishing Kits Make It Easy For Scammers To Steal Your ... anyone can get their hands on a DIY phishing kit, ... But it also touched on another important point about how ... these kits are often implemented, “like compromising legitimate content management ...
Breaking Medicine News(10 mins):Health News:India Coronary Stent Market 2019 Forecasts Analysis in New Research Report Available at MarketReportsOnline.com 2Health News:India Coronary Stent Market 2019 Forecasts Analysis in New Research Report Available at MarketReportsOnline.com 3Health News:Classic Denture Center in Portland Oregon is Offering March Discount 2Health News:New Gene Therapy Procedure Could Hold Key to Preventing Blindness for Certain Patients 2Health News:Pismo Beach Dentist Announces Special for Zoom! Teeth Whitening 2Health News:DIY Phishing and Malware Kits Make it Easy to Compromise Businesses in More Ways than One 2Health News:DIY Phishing and Malware Kits Make it Easy to Compromise Businesses in More Ways than One 3Health News:DIY Phishing and Malware Kits Make it Easy to Compromise Businesses in More Ways than One 4
... In keeping with the American Institute of Ultrasound ... safe and effective use of ultrasound in medicine ... AIUM recognizes the American College of Emergency Physicians ... the qualifications for performing ultrasound in the emergency ...
... , THURSDAY, Dec. 8 (HealthDay News) -- The brains of ... of streets and places of interest over several years, a ... learning can lead to changes in the adult brain, which ... after brain injury, according to the U.K. researchers. The ...
... are reporting they are burned out and dissatisfied with their ... Nursing,s Center for Health Outcomes and Policy Research in a ... 20 to 60 percent of nurses reported symptoms of burnout ... for Quality in Health Care , which collected data from ...
... Copenhagen have explored the active principles of a Danish mushroom ... particularly toxic towards cancer cells. The goal is to synthesise ... in future drug development. Asia has a long ... products. Many substances found in fungi are today registered as ...
... quarter century in Australia, cancer incidence rates have increased while ... the findings of a recent study published early online in ... with any other disease group, cancer has the greatest overall ... cancer and one in five dying from it before the ...
... -- A stressful early pregnancy could lower a woman,s odds ... delivery, a new study suggests. The findings from an ... affected pregnant women in Chile suggest that pregnancy can be ... that often accompany or cause stress, such as poverty, the ...
Cached Medicine News:Health News:AIUM officially recognizes ACEP Emergency Ultrasound Guidelines 2Health News:Taxi Drivers Show How Learning Changes Adult Brain 2Health News:To keep nurses, improve their work environments 2Health News:Danish mushroom inspires cancer researchers 2Health News:Danish mushroom inspires cancer researchers 3Health News:Study sheds light on cancer burden in Australia 2Health News:Stress Early in Pregnancy Linked to Fewer Baby Boys 2
(Date:2/27/2015)... N.J., Feb. 27, 2015  PTC Therapeutics, Inc. (NASDAQ: ... and reported financial results for the fourth quarter and ... "2014 was a transformative year for PTC. We are ... and developing RNA-targeted therapies in the rare disease space," ... Therapeutics, Inc. "We are proud to bring the first ...
(Date:2/27/2015)...  Bionik Laboratories Corp. (OTC:DWTPD), a Delaware ... acquired Bionik Laboratories, Inc., a Toronto ... qualified accredited investors of units consisting of its common ... $6.2 million. Shares of the Company,s common stock will ... the symbol "DWTPD" until FINRA,s approval of the ticker ...
(Date:2/26/2015)... , February 27, 2015 ... H2 2014 market research report to its store. ... Corneal Ulcers, therapeutic pipeline. The report ... on the therapeutic development for Corneal Ulcers. Corneal ... that includes bacterial infections, viral infections & fungal ...
Breaking Medicine Technology:PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 2PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 3PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 4PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 5PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 6PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 7PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 8PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 9PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 10PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 11Bionik Laboratories Raises $6.2 Million 2Bionik Laboratories Raises $6.2 Million 3Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 2Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 3Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 4Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 5
... , April 29 Abraxis BioScience initially ... the former ICN/Valient Pharmaceutical building in Costa Mesa, ... foot building. The "due diligence report" revealed an array ... occupying the building, and once the building purchase was ...
... April 29 Dendreon Corporation (Nasdaq: ... Food and Drug Administration (FDA) has approved PROVENGE® ... of asymptomatic or minimally symptomatic metastatic, castrate-resistant (hormone-refractory) ... an immune response against prostatic acid phosphatase (PAP), ...
Cached Medicine Technology:LCS Constructors, Inc. Completes First Major Phase of Abraxis BioScience Project 2FDA Approves PROVENGE(R) for the Treatment of Men with Advanced Prostate Cancer 2FDA Approves PROVENGE(R) for the Treatment of Men with Advanced Prostate Cancer 3FDA Approves PROVENGE(R) for the Treatment of Men with Advanced Prostate Cancer 4FDA Approves PROVENGE(R) for the Treatment of Men with Advanced Prostate Cancer 5FDA Approves PROVENGE(R) for the Treatment of Men with Advanced Prostate Cancer 6FDA Approves PROVENGE(R) for the Treatment of Men with Advanced Prostate Cancer 7
Performa cemented stem....
Porous foundation 480 series....
Porous foundation 440 series....
A cementless femoral stem that promotes bone in-growth and reduces thigh pain....
Medicine Products: